Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
J. Wang
Institution:
Jiangsu Province Hospital
Observed institution:
Jiangsu Province Hospital
OpenAlex ID:
A5042482842
2139P SKB315, a novel claudin 18.2 (CLDN18.2) antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors including gastric/ gastroesophageal junction cancer (GC/GEJC): A phase I study
2025
·
T. Deng
, J. Zhang
, et al.
·
Annals of Oncology
·
2
P175 Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in MBC
2015
·
B. Wang
, J. Zhang
, et al.
·
The Breast
·
1
Enhanced Survival in Stage IV NSCLC Patients: A Comparison of Sequential vs. Concurrent Radiotherapy Combined with Immunotherapy
2025
·
Y. Wang
, J. Wang
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
71 (PB059): The efficacy and safety of a selective PARP1 inhibitor ACE-86225106 in patients with advanced solid tumors: preliminary results from a first-inhuman phase 1/2 study
2024
·
S. Liu
, J. Zhang
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
4
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type